🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Stellar presentation David Kirsch, MD, PhD First trial on adding IO in #sarcoma #neoadjuvant #adjuavnt pembrolizumab to preop RT and surgery to >5cm G2/3 pleomorphic sarcoma/DDLiposarcoma improved disease free survival HR 0.57, 2yrDFS 55% to 73%. SARC Australia and New Zealand Sarcoma Association

Our author reflections on the use of augmented reality in retroperitoneal sarcomas. David Gyorki Hayden Snow Annals of Surgical Oncology Sheba Medical Center Peter Mac Cancer Centre link.springer.com/article/10.124…

Check out results of one of the TR projects of the Italian Sarcoma Group GEIS French and Polish Sarcoma Group neoad chemo trial on high-risk soft tissue #sarcoma of the extremity and trunk wall! kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

October Issue: 3D-SARC: A Pilot Study Testing the Use of a 3D Augmented-Reality Model with Conventional Imaging as a Preoperative Assessment Tool for #SurgicalResection of Retroperitoneal #Sarcoma Eyal Mor David Gyorki rdcu.be/dXdGG Meredith Gunder, MD Syed A. Ahmad

This is an incredibly important position paper on prophylactic salpingectomy and risk-reducing surgery. As surgeons, we should consider adopting this simple, low-risk procedure during appropriate surgeries to actively contribute to cancer prevention. obgyn.onlinelibrary.wiley.com/doi/10.1002/ij…

Inspiring #AMC2024 discussions: 'Overview of peri-operative systemic therapies'- neodjuvant therapy, histopathology & surgery considerations, personalised vaccines, clinical stage II & III melanoma @amenzies9 Rachel Roberts-Thomson David Gyorki Inês Pires da Silva #VictoriaAtkinson #RobertRawson

Great first day at #AMC2024 in Sydney! Amazing to see everyone come together to tackle melanoma with fresh ideas and real passion. #MelanomaResearch #OncologyCommunity

A great talk on surgical considerations in melanoma at #AMC2024!!!#MelanomaCare #OncologyInsights

Gene expression in Melanoma #amc2024

Very interesting discussion on locoregional therapies in the modern age of melanoma. #amc2024

Join us for the TARPSWG semiannual meeting at #CTOS2024 in beautiful #SanDiego , where we’re diving into the latest in #retroperitoneal #sarcoma research and treatment! Looking forward to discussions and updates! Alessandro Gronchi @SoMe4sarcoma Jason Sicklick CTOS

Kicking off the TARPSWG meeting at #CTOS2024 is Dr. HaydenSnow from 🇦🇺 presenting in the #hererogeneity of #patterns of #care of #retroperitonealsarcomas. Wide variations also seen amongst #highvolume centres. #sarcomas #CTOSTweeTOS Alessandro Gronchi Marco Fiore, MD, FACS, FEBSh Jason Sicklick

Peter Mac Cancer Centre CTOS Thanks to this wonderful collaboration with global colleagues - particularly the energy and leadership of Marco Fiore, MD, FACS, FEBSh Alessandro Gronchi and to the incredible effort of colleagues at home Hayden Snow Eyal Mor and A/Prof Catherine Mitchell.

2/4 the implication of histologic organ infiltration for surgical strategy and risk of recurrence, the natural history of PEComa, the outcome over time of a very large series of RPS patients treated at a single Institution with implications for the management of the RPS types

Thanks Alessandro Gronchi and TARPSWG ! #RESAR database is an unprecedented occasion to foster insights on #retroperitoneal sarcoma... New research projects are underway on prospective data from 2700+ RPS David Gyorki

Something’s cooking at the Laboratory for Surgical Innovation at the ARC, Sheba Medical Center. New tech. Bold ideas. Smarter surgery. Stay tuned. Sheba Medical Center